Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. The firm focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The firm focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The firm operates in Japan, the United States, Europe, and China.
Follow-Up Questions
Takeda Pharmaceutical Co Ltd のCEOは誰ですか？
Mr. Christophe Weber は Takeda Pharmaceutical Co Ltd の President で、2014 から在籍しています。
TAK の株価パフォーマンスは？
TAK の現在の価格は $14.01 で、最終取引日から 0% increased 変動しました。
Takeda Pharmaceutical Co Ltd の主な事業テーマや業界は？
Takeda Pharmaceutical Co Ltd は Pharmaceuticals 業界、セクターは Health Care に属しています。
